Essity Q2 FY26 EBITA drops to SEK 4.11 billion; net sales rise 2.6% to SEK 35.06 billion

• Essity Q2 2026 net sales rose 2.6% to SEK 35.06 billion, with organic sales growth of 0.3%.
• EBITA fell to SEK 4.11 billion, while profit for the period slipped to SEK 2.69 billion.
• Earnings per share declined to SEK 3.94; EBITA margin excluding IAC narrowed 0.3 percentage points to 13.4%.
• Health & Medical, Personal Care, and Professional Hygiene posted growth, while Consumer Tissue sales declined on lower prices and volumes.
• A new SEK 3 billion share buyback program started May 12, 2026, as management flagged higher cost inflation tied to geopolitics.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Essity AB (publ) published the original content used to generate this news brief via Cision (Ref. ID: 20260715:BIT:9334:0) on July 16, 2026, and is solely responsible for the information contained therein.